Pharmacological treatment of multiple sclerosis

Dátum
2014-06-27T13:22:11Z
Folyóirat címe
Folyóirat ISSN
Kötet címe (évfolyam száma)
Kiadó
Absztrakt

Because of autoimmunity nature of MS the main therapy is focused on immunosuppressant or immunomodulation. IFN-b and Glatimer acetate with minimal side effect profile and high efficiency to decrease relapse rate can be taken as first line treatment compared to other drugs. Mitoxantron, monoclonal antibodies, natalizumab and alemtuzumab can improve symptoms by immunosuppressory effect. Fingolimod has been shown best efficiency in aggressive form of MS as second line treatments. Vitamin D has anti-inflammatory and immunomodulatory effect which can be taken as supplementation in MS patients. Use of high dose of prednisolon or IVIG has been shown to decrease severity of symptoms and recovery significantly in relapse phase. In symptomatic management, benefit and side effects of drugs are evaluated to identify the best option of symptomatic treatment.

Leírás
Kulcsszavak
Multiple Sclerosis, Pharmacological treatmnt
Forrás